In this study, we assayed and investigated the status of EGFR, KRAS, MET, ALK, ROS1, HER2, RET, BRAF, NRAS, and PIK3CA somatic driver gene alterations derived from 851 Chinese NSCLC patients. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.